Subscription ARR: Approximately $1.2 billion, growing 38% year over year. Net New Subscription ARR: $89 million in the first quarter. Subscription Revenue: $266 million, growing 54% year over year. Subscription NRR: Above 120%. Customers with $100,000+ in Subscription ARR: 2,381, growing 28% year over year. Subscription ARR Contribution Margin: Improved over 1,800 basis points year
Revenue: $139 million in Q1 2025, representing 28% growth over Q1 2024. Crysvita Revenue: $103 million, with 25% growth over 2024; $41 million from North America, $55 million from Latin America and Turkey, $7 million from Europe. Dojolvi Revenue: $17 million, consistent with steady growth. Evkeeza Revenue: $11 million, with increasing demand following launches outside
Q: Tim, can you provide a framework for thinking about tariffs on the revenue side and how they might affect your ability to take market share? A: Tim Breen, CEO: We haven’t seen significant short-term impacts from tariffs on orders. However, for the second half of 2025 and into 2026, the broader impact remains uncertain.
Revenue: $87.7 million for Q1 2025. Cash from Operations: $57.1 million generated in Q1 2025. Operating Expenses: $40.9 million, a 4% increase from the prior quarter. Research and Development Expenses: Increased by $362,000 or 2% from the prior quarter. Selling, General, and Administrative Expenses: Decreased by $964,000 or 5% from the prior quarter. Litigation Expense:
Total Revenue: $42.3 billion, up 16% year-over-year. Total Expenses: $24.8 billion, up 9% year-over-year. Operating Income: $17.6 billion, representing a 41% operating margin. Free Cash Flow: $10.3 billion. Cash and Marketable Securities: $70.2 billion. Debt: $28.8 billion. Family of Apps Revenue: $41.9 billion, up 16% year-over-year. Family of Apps Ad Revenue: $41.4 billion, up 16%
Revenue: $447.7 million, an increase of 5.7% over the prior year. Net Income: $17.2 million. Diluted EPS: $0.23 per share. Cash Flow from Operations: $32.1 million, an increase of $41.3 million over the prior year. Environmental Services Revenue: $196.3 million with a margin of 10.8%. Dietary Services Revenue: $251.3 million with a margin of 7.6%.
General Industrial Machinery Stocks Q4 Results: Benchmarking John Bean (NYSE:JBTM) As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the general industrial machinery industry, including John Bean (NYSE:JBTM) and its peers. Automation that increases efficiency and connected equipment that collects analyzable data have been trending, creating new demand
Q: To what degree should we expect most of the revenue growth being in the second half due to the government’s inability to issue new program start contracts until a final budget is put into place? A: Thomas Krywe, Interim CFO, explained that the growth in the second half is largely due to the flow
General Industrial Machinery Stocks Q4 Recap: Benchmarking Kadant (NYSE:KAI) Let’s dig into the relative performance of Kadant (NYSE:KAI) and its peers as we unravel the now-completed Q4 general industrial machinery earnings season. Automation that increases efficiency and connected equipment that collects analyzable data have been trending, creating new demand for general industrial machinery companies. Those
Unpacking Q4 Earnings: 3M (NYSE:MMM) In The Context Of Other General Industrial Machinery Stocks The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how 3M (NYSE:MMM) and the rest of the general industrial machinery